The question bank is the fastest way to start, but PMHNP Helper also includes board-review planning, student resources, and plain-English guidance for psychiatric nurse practitioner students who are still learning the exam landscape.
A 9-year-old boy is brought to the clinic by his parents after his teacher reported persistent inattention, difficulty remaining seated, and frequent interrupting in class over the past eight months. His parents confirm similar behaviors at home, including an inability to complete homework and frequent losing of personal items. A comprehensive evaluation confirms a diagnosis of ADHD, combined presentation, with a Vanderbilt score consistent with moderate severity. He has no history of tics, seizures, cardiac abnormalities, or substance exposure, and his vital signs are within normal pediatric limits. The PMHNP is developing an initial treatment plan. Which of the following best represents the most appropriate first-line treatment approach for this patient?
Explanation
For school-age children aged 6 and older with moderate ADHD, current guidelines recommend combined treatment with FDA-approved stimulant medication and behavioral interventions as the first-line approach. The MTA study demonstrated the superiority of this strategy over behavioral therapy alone for core symptom reduction.
Key Takeaway
First-line treatment for school-age children with moderate ADHD involves combined FDA-approved stimulant pharmacotherapy and behavioral interventions, as supported by the MTA study and current AAP guidelines.